About the SEARCH Database
The Shared Equal Access Regional Cancer Hospital (SEARCH) database is a database of prostate cancer patients at eight Veterans Affairs hospitals across the country including the San Diego, CA; Greater Los Angeles, CA; Palo Alto, CA; San Francisco, CA; Portland, OR; Augusta, GA; Asheville, NC; and Durham, NC centers. The database is associated with prominent research institutions including Cedars-Sinai Medical Center; Duke University; University of California, San Diego; David Geffen School of Medicine at UCLA; University of California, San Francisco; Oregon Health Sciences University; and Georgia Regents University.
The purpose of the SEARCH database is to take full advantage of the strength of the VA population for prostate cancer and the VA electronic medical record system for research purposes. The SEARCH database was formed in late 2000 under the leadership of Dr. Stephen Freedland, and the group published their first paper on the role of race predicting prostate cancer outcomes after radical prostatectomies in October 2002. Since that time, the group has published over 120 manuscripts including one in Journal of the American Medical Association, two in the Journal of Clinical Oncology, and three in European Urology (the top rated Urology journal in the world); amounting to a new manuscript every other month for the past fourteen+ years.
We have a dedicated full-time staff including research coordinators, programmers, statisticians, clinical trials assistants, and data technicians. Due to the strength of the VA system, the database team, which is located in Durham, NC has access to all electronic medical records for all subjects in the entire VA system. Thus, from one central location, we are able to track the outcomes of all men with prostate cancer in SEARCH. It is this type of centralization combined with the strong drive of the SEARCH investigative team that has resulted in over 120 manuscripts to date. Though to date our efforts have largely been focused on radical prostatectomy patients, we are actively in the process of expanding the database to include all men diagnosed with prostate cancer at all sites.